Director, Pediatric Stem Cell Transplant & Cellular Therapies

Director, Pediatric Stem Cell Transplant & Cellular Therapies The Department of Pediatrics at NYU Grossman School of Medicine and Hassenfeld Children’s Hospital at NYU Langone Health is seeking a full‑time academic physician to join the Division of Pediatric Hematology-Oncology as Director of Pediatric Stem Cell Transplant and Cellular Therapies. The Director will lead an expanding, FACT‑accredited pediatric stem cell and cellular therapy program, with responsibility for clinical, operational, research, and educational activities. The program provides blood, bone marrow, and stem cell transplantation and cellular therapies to children and adolescents across the full spectrum of malignant and non‑malignant hematologic and oncologic diseases. Strategic leadership of the pediatric BMT and cellular therapies program. Provision of clinical care in inpatient and ambulatory settings. Education and research within the division. Fostering programmatic development and scholarly activities. The Director will have access to a rich ecosystem of resources including the Perlmutter Cancer Center, an NCI‑designated Comprehensive Cancer Center, and world‑class researchers in cancer, immunology, stem cell biology, and developmental therapeutics. Academic appointment will be commensurate with experience and expertise. Applicants from the Associate Professor and Professor level are preferred. Applicants must be board certified or eligible in Pediatric Hematology‑Oncology and licensed (or eligible for licensure) in NewYork State. Salary Range: $260,000 – $300,000. Actual salary may vary based on experience, training, and other factors. Salary range listed is for full‑time employment and does not include benefits. NYU Langone Health is an equal opportunity and affirmative action employer committed to diversity and inclusion. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity, sexual orientation, national origin, age, religion, creed, disability, military and veteran status, genetic information, or any other factor which cannot lawfully be used as a basis for an employment decision. Interested individuals should submit a letter of interest and curriculum vitae electronically and complete an application online. Letters should be addressed to Dr. Lisa Roth, Division Director, Pediatric Hematology‑Oncology. Application period: September1–December31,2026. Posted: May14,2026. #J-18808-Ljbffr